TrialThe oncologist2016

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.

Dickran Kazandjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.